Metabolic Disorders and Vertigo
Metabolic Disorders and Their Correction in Vertigo and Unsteadiness
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of investigation is to assess the levels of metabolic factors (hydroxyvitamin D, homocysteine) between patients with vestibular dysfunction of peripheral origin (BPPV) and central origin (vestibular migraine). Also we will analyse another factors (such as anxiety and depression) and optimize therapeuthical approach accordingly with the data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2019
CompletedFirst Submitted
Initial submission to the registry
April 11, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedJune 23, 2021
March 1, 2021
2.1 years
April 11, 2021
June 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
vitamin D deficiency/insufficiency reveal
enzyme-linked immunosorbent assay (ELISA).
Through 1-6 months of diagnosis established.
hyperhomocysteinaemia reveal
enzyme-linked immunosorbent assay (ELISA).
Through 1-6 months of diagnosis established.
Secondary Outcomes (1)
correlation between metabolic and neuropsychological disorders
through study completion, an average of 1 year
Study Arms (3)
patients with peripherial vestibular disorder
Forty patients with BPPV, vestibular neuritis or another peripherial vestibular disorder
patients with central vestibular disorder
Forty patients vestibular disorder of central origin
healthy controls
twenty healthy control without balance problems
Interventions
vitamin D deficiency/insufficiency reveal, hyperhomocysteinaemia reveal
neuropsychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'scale.
Eligibility Criteria
patients from clinic with damage of peripheral and central origin
You may qualify if:
- Written informed consent of participation in the study;
- Age:over 18 years old
- complaints of dizziness and insteadiness
You may not qualify if:
- Severe cognitive impairment (dementia)
- Severe depression
- Syncopal paroxysms
- Epileptic seizures
- Orthostatic hypotension
- Severe arrhythmia, unstable angina pectoris, acute myocardial infarction
- Pregnancy 8. Alcoholism, substance abuse and drug addiction
- Organic liver and kidney diseases with the development of functional disorders.
- Anemia (hemoglobin \<10.5 g / dl for women and \<11.5 g / dl for men)
- Active oncological process
- Demyelinating and neurodegenerative diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinic of Neurology and Neurosurgery of I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia
Related Publications (4)
Bedenko A.S., Antonenko L.М., Barinov A.N. Metabolic disorders in the pathogenesis of various causes of dizziness and instability // Annals of the Russian academy of medical sciences. - 2020. - Vol. 75. - N. 6. - P. 605-608. doi: 10.15690/vramn1244
BACKGROUNDBedenko A.S. Vertigo in neurological practice: rare causes and difficult decisions. Medical alphabet. 2019;2(19):34-36. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-19(394)-34-36
BACKGROUNDBedenko A.S. Metabolic factors in pathogenesis of migraine and unsteadiness. Medical alphabet. 2020;(33):18-20. (In Russ.) https://doi.org/10.33667/2078-5631-2020-33-18-20
BACKGROUNDBedenko A.S. Vertigo caused by vestibular migraine: current problems of pathogenesis, diagnostics and therapy. Epilepsy and paroxysmal conditions. 2020;12(3):177-181. (In Russ.)https://doi.org/10.17749/2077-8333/epi.par.con.2020.032
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Bedenko, PhD student
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2021
First Posted
June 23, 2021
Study Start
December 10, 2019
Primary Completion
December 30, 2021
Study Completion
August 31, 2022
Last Updated
June 23, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share
I give my consent to provide actual study protocol. However, It is impossible to provide stastistical documents and primary patient's documentation (It is forbidden by Local Ethic Committee of Sechenov University)